Newswise News from Weber & Associates Latest news from Weber & Associates on Newswise en-us Copyright 2024 Newswise Newswise News from Weber & Associates 115 31 / /images/newswise-logo-rss.gif HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials /articles/hivaids-research-network-recommends-use-of-abbott-realtime-viral-load-test-for-nih-sponsored-clinical-trials/?sc=rsin /articles/hivaids-research-network-recommends-use-of-abbott-realtime-viral-load-test-for-nih-sponsored-clinical-trials/?sc=rsin Fri, 08 May 2009 10:30:00 EST The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH). Weber & Associates AIDS Research Pioneer Robert Gallo, M.D., Keynotes Abbott HIV Symposium, Oct. 24 /articles/aids-research-pioneer-robert-gallo-md-keynotes-abbott-hiv-symposium-oct-24/?sc=rsin /articles/aids-research-pioneer-robert-gallo-md-keynotes-abbott-hiv-symposium-oct-24/?sc=rsin Mon, 06 Oct 2008 12:25:00 EST On Friday, October 24 at 3 p.m. at the National Press Club in Washington, D.C., Abbott will host a symposium titled: HIV Diagnosis and Therapy, Beyond B: Challenges for the Future. The keynote speaker is Robert Gallo, M.D., known worldwide for identifying the HIV virus in 1984 as the causative agent of AIDS. Weber & Associates